The Pharmaceutical Plant Co Pty Ltd v TP Health Ltd

The Pharmaceutical Plant Co Pty Ltd (the applicant) sought an interlocutory injunction against TP Health Ltd (the respondent) to restrain the respondent from infringing the applicant's registered trade mark, "PHARMACEUTICAL PLANT" and associated logos. The dispute concerned the respondent's use of the mark "TP HEALTH PHARMACEUTICAL PLANT" and similar branding in relation to its own pharmaceutical products. The application was heard in the Federal Court of Australia.

The primary legal issues before the court were whether the applicant had established a serious question to be tried regarding the alleged trade mark infringement and whether the balance of convenience favoured the grant of an interlocutory injunction. Specifically, the court had to consider the likelihood of confusion or deception among consumers arising from the respondent's use of the impugned mark, and whether the applicant would suffer irreparable harm if the injunction were not granted.

In its reasoning, the court applied the principles governing interlocutory injunctions, including the two-stage test established in *Australian Broadcasting Corporation v O’Neill*. This requires the applicant to demonstrate a serious question to be tried and then for the court to consider the balance of convenience. The court assessed the strength of the applicant's case by examining the similarity of the marks, the similarity of the goods, and the likelihood of consumers being deceived or confused. The balance of convenience involved weighing the potential harm to the applicant if the injunction was refused against the potential harm to the respondent if it was granted.

The court ultimately granted the interlocutory injunction, finding that the applicant had established a serious question to be tried and that the balance of convenience favoured the grant of the injunction. The respondent was restrained from using the impugned mark pending the final determination of the proceedings.